{
    "2021-10-27": [
        [
            {
                "time": "",
                "original_text": "上海医药子公司拿下两款益生菌新药独占许可权益",
                "features": {
                    "keywords": [
                        "上海医药",
                        "子公司",
                        "益生菌",
                        "新药",
                        "独占许可"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上海医药：子公司与KoBioLabs就益生菌项目达成合作",
                "features": {
                    "keywords": [
                        "上海医药",
                        "子公司",
                        "KoBioLabs",
                        "益生菌",
                        "合作"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "行研 | 国药、华润、上药等流通商是医院心头好，原因在哪？",
                "features": {
                    "keywords": [
                        "国药",
                        "华润",
                        "上药",
                        "流通商",
                        "医院"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "流通"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药：子公司与KoBioLabs公司就益生菌KB697、KB693项目进行合作",
                "features": {
                    "keywords": [
                        "上海医药",
                        "子公司",
                        "KoBioLabs",
                        "益生菌",
                        "KB697",
                        "KB693",
                        "合作"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}